Medicine
Carboplatin 600 mg/60 mL injection
Carboplatin 600 mg/60 mL injection is a generic prescription medicine for intravenous use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Unopened vials of carboplatin injection are stable to the date indicated on…
Key facts
- Active ingredient (INN)
- Carboplatin
- Brand
- Sold under the generic name
- Strength
- 600 mg/60 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 60 mL and 10 more
- Manufacturers
- EugiaIndiaAccord HealthcareIndiaGland PharmaIndiaNatco PharmaIndiaTeyro LabsIndiaHospiraTeva Parenteral MedicinesApotexBPI LabsFresenius Kabi
- Origin register
- US FDA, United States
- Storage
- Unopened vials of carboplatin injection are stable to the date indicated on the package when stored at 20° to 25°C (68° to 77°F). Carboplatin injection multidose vials maintain microbial, chemical, and physical stability for up to 14 days at 25°C following multiple needle entries. PROTECT FROM LIGHT.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01XA02 Carboplatin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 October 2004
- Identifiers
- RxCUI 597195DailyMed set ID 1c275825-0275-4c73-b650-e4c1519f13b8, f5fe9a20-47a5-45b9-ab06-c6158d9b6aca, 9eb057eb-29ce-40d2-9ac8-ed107f25f5ab +10NDC 60505-6282, 55150-386, 68083-193 +8Application ANDA077861, ANDA205487, ANDA207324 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 55150-386-00 | EugiaIndia | 3 August 2020 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 55150-386-01 | EugiaIndia | 3 August 2020 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 16729-295-12 | Accord HealthcareIndia | 3 October 2017 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 68083-193-01 | Gland PharmaIndia | 20 February 2017 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 69339-367-60 | Natco PharmaIndia | 2 July 2026 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 82511-006-60 | Teyro LabsIndia | 24 August 2023 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 61703-339-56 | Hospira | 23 November 2004 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 61703-600-05 | Hospira | 23 May 2022 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 0703-4239-01 | Teva Parenteral Medicines | 23 October 2014 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 0703-4239-81 | Teva Parenteral Medicines | 19 January 2016 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 60505-6282-7 | Apotex | 10 January 2024 |
| 1 vial, multi-dose in 1 carton / 60 mL in 1 vial, multi-dose | 54288-167-01 | BPI Labs | 31 July 2023 |
| 1 vial in 1 box / 60 mL in 1 vial | 63323-172-60 | Fresenius Kabi | 11 December 2009 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 3 March 1989 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Carboplatin
Clinical summary
Carboplatin is a platinum-based drug indicated in adults, among other approved uses. It is available as injection for intravenous use. MedsAcross supplies Carboplatin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CarboplatinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KYXATA prescribing information (Avyxa Pharma) · U.S. National Library of Medicine, DailyMed
Need Carboplatin 600 mg/60 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.